CancerVax
 CancerVax was an American pharmaceutical company founded in 1998 by Donald Morton. The company sought to develop a vaccine for cancer and had candidates for melanoma reach phase III clinical trials. When those trials proved unsuccessful in 2005 the company soon underwent a reverse takeover with Micromet.